[1]朱芳丽,马厉英,马晓莹,等.急性胰腺炎患者血清CXC趋化因子配体10和CC类趋化因子22水平与疾病严重程度关系及临床诊断价值研究[J].陕西医学杂志,2024,(6):788-792.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.014]
　ZHU Fangli,MA Liying,MA Xiaoying,et al.Relationship between serum CXCL10,CCL22 levels and disease severity in patients with acute pancreatitis and their clinical diagnostic value[J].,2024,(6):788-792.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.014]
点击复制

急性胰腺炎患者血清CXC趋化因子配体10和CC类趋化因子22水平与疾病严重程度关系及临床诊断价值研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年6期
页码:
788-792
栏目:
临床研究
出版日期:
2024-06-05

文章信息/Info

Title:
Relationship between serum CXCL10,CCL22 levels and disease severity in patients with acute pancreatitis and their clinical diagnostic value
作者:
朱芳丽; 马厉英; 马晓莹; 韩俊岭
(秦皇岛市第一医院消化内科,河北 秦皇岛 066000)
Author(s):
ZHU Fangli; MA Liying; MA Xiaoying; HAN Junling
(Department of Gastroenterology,First Hospital of Qinhuangdao,Qinhuangdao 066000,China)
关键词:
急性胰腺炎;  CXC趋化因子配体10;  CC类趋化因子22;  疾病严重程度;  肝功能指标;  肾功能指标;  诊断价值
Keywords:
Acute pancreatitis;  CXC chemokine ligand 10;  CC class chemokine 22;  Disease severity;  Liver function indexes;  Renal function indexes;  Diagnostic value
分类号:
R 657.51
DOI:
DOI:10.3969/j.issn.1000-7377.2024.06.014
文献标志码:
A
摘要:
目的:分析急性胰腺炎患者血清CXC趋化因子配体10(CXCL10)和CC类趋化因子22(CCL22)水平与疾病严重程度的关系及临床诊断价值。方法:选取急性胰腺炎患者102例,分为轻症组(轻症急性胰腺炎患者,47例)、中度重症组(中度重症急性胰腺炎患者,31例)和重症组(重症急性胰腺炎患者,24例)。选择52例体检健康者为健康组。采用全自动生化分析仪检测受试者肝功能指标[丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)]、肾功能指标[肌酐(Scr)、血尿素氮(BUN)]以及淀粉酶(AMY)水平。采用酶联免疫吸附法检测血清中CXCL10、CCL22水平。采用急性胰腺炎严重程度床边指数(BISAP)评分评估急性胰腺炎患者疾病严重程度。采用Logistic回归分析中度重症和重症急性胰腺炎发生的影响因素。采用Pearson法分析急性胰腺炎患者血清CXCL10、CCL22水平及BISAP评分间的相关性。采用受试者工作特征(ROC)曲线评价血清CXCL10、CCL22水平诊断中度重症和重症急性胰腺炎的价值。结果:与健康组比较,轻症组ALT、Scr、BUN、AMY水平升高,中度重症组和重症组ALT、AST、Scr、BUN、AMY水平升高(均P<0.05)。与轻症组比较,中度重症组BUN水平升高,重症组ALT、AST、Scr、BUN水平升高(均P<0.05)。与中度重症组比较,重症组BUN水平升高(P<0.05)。四组血清CXCL10、CCL22水平及BISAP评分依次升高(均P<0.05)。急性胰腺炎患者血清CXCL10和CCL22水平呈正相关(P<0.05); 血清CXCL10、CCL22水平与BISAP评分呈正相关(均P<0.05)。血清CXCL10、CCL22、BISAP评分是中度重症和重症急性胰腺炎发生的独立危险因素(均P<0.05)。血清CXCL10、CCL22对中度重症和重症急性胰腺炎均有一定诊断价值,且两项联合诊断价值更高(均P<0.05)。结论:急性胰腺炎患者血清CXCL10、CCL22水平呈高表达,且随疾病严重程度的加重而升高,两者联合诊断中度重症和重症急性胰腺炎的价值较高。
Abstract:
Objective:o analyze the relationship between serum CXC chemokine ligand 10(CXCL10),CC class chemokine 22(CCL22)levels and disease severity in patients with acute pancreatitis and their clinical diagnostic value.Methods:A total of 102 patients with acute pancreatitis were enrolled and divided into mild group(47 patients with mild acute pancreatitis),moderately severe group(31 patients with moderate severe acute pancreatitis)and severe group(24 patients with severe acute pancreatitis).Fifty-two healthy people were selected as the healthy group.The levels of liver function indexes(ALT and AST),renal function indexes(Scr and BUN)and amylase(AMY)were measured by automatic biochemical analyzer.The levels of CXCL10 and CCL22 in serum were detected by enzyme-linked immunosorbent assay.Disease severity of patients with acute pancreatitis were evaluated by BISAP score.Logistic regression was used to analyze the influencing factors of moderately severe pancreatitis and severe acute pancreatitis.Pearson method was used to analyze the correlation between serum CXCL10,CCL22 levels and BISAP score in patients with acute pancreatitis.The value of serum CXCL10 and CCL22 levels in the diagnosis of moderate severe acute pancreatitis and severe acute pancreatitis was evaluated by ROC curve.Results: Compared with healthy group,the levels of ALT,Scr,BUN and AMY were increased in mild group,and the levels of ALT,AST,Scr,BUN and AMY in moderately severe group and severe group were increased(all P<0.05).Compared with mild group,BUN level in moderately severe group were increased,and the levels of ALT,AST,Scr and BUN in severe group were increased(all P<0.05).Compared with moderately severe group,BUN level in the severe group was increased(P<0.05).Serum CXCL10,CCL22 levels and BISAP score in healthy group,mild group,moderately severe group and severe group were increased successively(all P<0.05).The serum levels of CXCL10 and CCL22 in patients with acute pancreatitis were positively correlated(P<0.05).Serum CXCL10 and CCL22 levels were positively correlated with BISAP scores(all P<0.05).Serum CXCL10,CCL22 and BISAP score were independent risk factors for moderately severe acute pancreatitis and severe acute pancreatitis(all P<0.05).Serum CXCL10 and CCL22 had certain diagnostic value for moderately severe acute pancreatitis and severe acute pancreatitis,and the combination of the two had higher diagnostic value(all P<0.05).Conclusion:Serum levels of CXCL10 and CCL22 are highly expressed in patients with acute pancreatitis,and increase with the severity of the disease.The combination of CXCL10 and CCL22 has a high value in the diagnosis of moderately severe acute pancreatitis and severe acute pancreatitis.

参考文献/References:

[1] 王敏,罗小华,卢娟娟.通腑解毒方联合六合丹辅助西医治疗急性胰腺炎临床研究[J].陕西中医,2023,44(4):471-474.
[2] GLAUBITZ J,WILDEN A,FROST F,et al.Activated regulatory T-cells promote duodenal bacterial translocation into necrotic areas in severe acute pancreatitis[J].Gut,2023,72(7):1355-1369.
[3] 侯燕燕,陈新卫,田颖,等.连续性肾脏替代治疗联合限制性液体复苏在重症急性胰腺炎治疗中的应用价值[J].陕西医学杂志,2023,52(12):1711-1714.
[4] CHAUHAN R,SAXENA N,KAPUR N,et al.Comparison of modified glasgow-imrie,ranson,and apache Ⅱ scoring systems in predicting the severity of acute pancreatitis[J].Pol Przegl Chir,2022,95(1):6-12.
[5] HAN F,SHI X L,PAN J J,et al.Elevated serum HbA1c level,rather than previous history of diabetes,predicts the disease severity and clinical outcomes of acute pancreatitis[J].BMJ Open Diabetes Res Care,2023,11(1):e003070.
[6] MOROI R,TARASAWA K,IKEDA M,et al.Severity of acute pancreatitis in patients with inflammatory bowel disease in the era of biologics:A propensity-score-matched analysis using a nationwide database in Japan[J].JGH Open,2022,7(1):40-47.
[7] HUOMAN J,HAIDER S,SIMPSON A,et al.Childhood CCL18,CXCL10 and CXCL11 levels differentially relate to and predict allergy development[J].Pediatr Allergy Immunol,2021,32(8):1824-1832.
[8] PURZYCKA-BOHDAN D,NEDOSZYTKO B,ZABLOTNA M,et al.Chemokine profile in psoriasis patients in correlation with disease severity and pruritus[J].Int J Mol Sci,2022,23(21):13330.
[9] 中华医学会消化病学分会胰腺疾病学组,中华胰腺病杂志编辑委员会,中华消化杂志编辑委员会.中国急性胰腺炎诊治指南(2019年,沈阳)[J].中华消化杂志,2019,39(11):721-730.
[10] CHATTERJEE R,PARAB N,SAJJAN B,et al.Comparison of acute physiology and chronic health evaluation Ⅱ,modified computed tomography severity index,and bedside index for severity in acute pancreatitis score in predicting the severity of acute pancreatitis[J].Indian J Crit Care Med,2020,24(2):99-103.
[11] 李辉,贾文秀,李风华,等.急性胰腺炎发病机制研究[J].胃肠病学和肝病学杂志,2020,29(4):379-383.
[12] GAO L,DONG X,GONG W,et al.Acinar cell NLRP3 inflammasome and gasdermin D(GSDMD)activation mediates pyroptosis and systemic inflammation in acute pancreatitis[J].Br J Pharmacol,2021,178(17):3533-3552.
[13] HU Q,YAO J,WU X,et al.Emodin attenuates severe acute pancreatitis-associated acute lung injury by suppressing pancreatic exosome-mediated alveolar macrophage activation[J].Acta Pharm Sin B,2022,12(10):3986-4003.
[14] 刘馨,王成中,李元明.益气活血解毒方治疗瘀毒互结型急性重症胰腺炎临床研究[J].陕西中医,2023,44(10):1387-1390.
[15] JU J,HE Y.PRMT5 promotes inflammation of cigarette smoke extract-induced bronchial epithelial cells by up-regulation of CXCL10[J].Allergol Immunopathol(Madr),2021,49(5):131-136.
[16] 杨谦,曹冰清,韩征,等.CXC趋化因子配体10在癫痫大鼠和细胞炎症反应中的作用及机制研究[J].陕西医学杂志,2022,51(12):1483-1487.
[17] OZGA A J,CHOW M T,LOPES M E,et al.CXCL10 chemokine regulates heterogeneity of the CD8+ T cell response and viral set point during chronic infection[J].Immunity,2022,55(1):82-97.
[18] HONG S H,KANG N,KIM O,et al.EGFR-Tyrosine kinase inhibitors induced activation of the autocrine CXCL10/CXCR3 pathway through crosstalk between the tumor and the microenvironment in egfr-mutant lung cancer[J].Cancers(Basel),2022,15(1):124-137.
[19] MUNJAL A,KHANDIA R.Atherosclerosis:Orchestrating cells and biomolecules involved in its activation and inhibition[J].Adv Protein Chem Struct Biol,2020,120(1):85-122.
[20] PENG C,TU G,WANG J,et al.MLKL signaling regulates macrophage polarization in acute pancreatitis through CXCL10[J].Cell Death Dis,2023,14(2):155-168.
[21] LI H,CHEN X,ZENG W,et al.Radiation-enhanced expression of CCL22 in nasopharyngeal carcinoma is associated with CCR4+ CD8 T cell recruitment[J].Int J Radiat Oncol Biol Phys,2020,108(1):126-139.
[22] BAER C,KIMURA S,RANA M S,et al.CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk[J].Nat Genet,2022,54(5):637-648.
[23] CHEN J,ZHAO D,ZHANG L,et al.Tumor-associated macrophage(TAM)-derived CCL22 induces FAK addiction in esophageal squamous cell carcinoma(ESCC)[J].Cell Mol Immunol,2022,19(9):1054-1066.
[24] WANG Q,SUDAN K,SCHMOECKEL E,et al.CCL22-polarized TAMs to M2a macrophages in cervical cancer in vitro model[J].Cells,2022,11(13):2027-2039.
[25] XU H,LIN S,HUANG H.Involvement of increased expression of chemokine C-C motif chemokine 22(CCL22)/CC chemokine receptor 4(CCR4)in the inflammatory injury and cartilage degradation of chondrocytes[J].Cytotechnology,2021,73(5):715-726.

相似文献/References:

[1]张玉亮,朱 宏,戴洪山△.B超引导经皮经肝胆囊穿刺引流术在胆源性胰腺炎治疗中的临床意义[J].陕西医学杂志,2019,(2):166.
　ZHANG Yuliang,ZHU Hong,DAI Hongshan..Clinical significance of Bmode ultrasound guided percutaneous transhepatic  gallbladder puncture and drainage in the treatment of biliary pancreatitis[J].,2019,(6):166.
[2]姜 萌,赵 鹏△.奥曲肽联合加贝酯治疗重症急性胰腺炎疗效及对患者血清细胞因子水平的影响[J].陕西医学杂志,2020,49(2):212.
　JIANG Meng,ZHAO Peng..Clinical efficacy of octreotide combined with gabexate in the treatment of severe acute pancreatitis and its effect on serum cytokine levels[J].,2020,49(6):212.
[3]刘 静.红细胞分布宽度联合降钙素原检测对急性胰腺炎严重程度及预后评估价值分析[J].陕西医学杂志,2020,49(4):470.
　LIU Jing..Value of Red cell distribution width combined with procalcitonin in evaluating the severity and prognosis of acute pancreatitis[J].,2020,49(6):470.
[4]朱绍华,何创业,赵 芯.血清微管相关蛋白1轻链3-Ⅱ、半胱氨酸天冬氨酸特异性蛋白酶-3及高迁移率族蛋白B1在不同程度急性胰腺炎中的表达及意义[J].陕西医学杂志,2022,51(9):1098.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.012]
　ZHU Shaohua,HE Chuangye,ZHAO Xin.Expression and significance of serum LC3-Ⅱ,Caspase-3 and HMGB1 in different degrees of acute pancreatitis[J].,2022,51(6):1098.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.012]
[5]杨 谦,曹冰清,韩 征,等.CXC趋化因子配体10在癫痫大鼠和细胞炎症反应中的作用及机制研究[J].陕西医学杂志,2022,51(12):1483.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.004]
　YANG Qian,CAO Bingqing,HAN Zheng,et al.Role and mechanism of CXC chemokine ligand-10 in inflammatory response of epileptic rats and cells[J].,2022,51(6):1483.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.004]
[6]刘 伟,支 媛,高 璐,等.急性胰腺炎患者血清微小RNA-340-3p、CXC趋化因子配体-13和CXC趋化因子配体-16的表达意义[J].陕西医学杂志,2023,52(1):97.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.023]
　LIU Wei,ZHI Yuan,GAO Lu,et al.Expressions and significance of miR-340-3p,CXCL-13 and CXCL-16in serum of patients with acute pancreatitis[J].,2023,52(6):97.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.023]
[7]佘育纯,路 勇,王建龙.血清基质金属蛋白酶-9、二胺氧化酶、Toll样受体9与急性胰腺炎患者疾病严重程度及肠黏膜屏障损伤相关性分析[J].陕西医学杂志,2023,52(3):292.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.010]
　SHE Yuchun,LU Yong,WANG Jianlong.Association of serum matrix metalloproteinase-9,diamine oxidase,and Toll-like receptor 9 with disease severity and intestinal mucosal barrier injury in patients with acute pancreatitis[J].,2023,52(6):292.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.010]
[8]吕 魁,孙俊峰,杨健鹰.血清C反应蛋白、降钙素原、D-二聚体在急性胰腺炎患者中的表达及与严重程度床边指数和肺损伤的相关性[J].陕西医学杂志,2023,52(10):1375.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.020]
[9]莫 闲,杨 闯.急性胰腺炎发病机制及并发内脏静脉血栓研究进展[J].陕西医学杂志,2024,(2):282.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.030]
　MO Xian,YANG Chuang.Research progress on pathogenesis of acute pancreatitis and concurrent splanchnic vein thrombosis[J].,2024,(6):282.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.030]
[10]刘维伟,王翠敏,刘平安,等.糖尿病足感染患者血清CXC趋化因子配体10和可溶性髓系细胞触发受体-1水平与病情、治疗效果的关系[J].陕西医学杂志,2025,54(3):349.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.012]
　LIU Weiwei,WANG Cuimin,LIU Ping'an,et al.Relationship between serum CXCL10,sTREM-1 levels and disease condition,therapeutic efficacy in patients with diabetic foot infection[J].,2025,54(6):349.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.012]

备注/Memo

备注/Memo:
基金项目:河北省医学科学研究课题(20221312)
更新日期/Last Update: 2024-06-05